secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oric Pharmaceuticals, Inc. (ORIC)
CIK:        0001796280
Form:       8-K
Filed at:   2022-03-04T23:59:59+00:00
Accession:  0001193125-22-066051
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ORIC Pharmaceuticals adopts 2022 Inducement Equity Incentive Plan reserving 500,000 shares
--------------------------------------------------------------------------------

- Plan adopted March 1, 2022 by Compensation Committee; 500,000 shares of common stock reserved.
- Awards limited to new employees as material inducement to hire, per Nasdaq Listing Rule 5635(c)(4).
- Terms substantially similar to company's 2020 Equity Incentive Plan.
- Adopted without stockholder approval; approved by independent directors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1796280/000119312522066051/0001193125-22-066051-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1796280/000119312522066051/d253295d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-066051

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer